Biolinco
Techstars '26Baltimore, US · Founded 2023 · 2 employees on LinkedIn · 1 known investors
Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.
Founders & leadership
Biolinco was founded in 2023 by Kent Rapp, PhD., Junneng (Kevin) Wen, PhD., Reza Kalhor, PhD., and Michael Betenbaugh, PhD..
KR
Kent Rapp, PhD.Co-Founder & CEO
J(
Junneng (Kevin) Wen, PhD.Co-Founder & CTO
RK
Reza Kalhor, PhD.Scientific Co-Founder
MB
Michael Betenbaugh, PhD.Scientific Co-Founder
KR
Kent Rapp
KW
Kevin WenPhD
Investors · 1
Frequently asked questions
- What does Biolinco do?
- Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.
- Who founded Biolinco?
- Biolinco was founded by Kent Rapp, PhD., Junneng (Kevin) Wen, PhD., Reza Kalhor, PhD., Michael Betenbaugh, PhD. in 2023.
- Who are Biolinco's investors?
- Biolinco's investors include Techstars.
- Where is Biolinco headquartered?
- Biolinco is headquartered in Baltimore, US.